Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
GMRS
BuyUnloved QualityFLAGGMR Solutions Inc. · Healthcare · United States · $681M · Avg Vol: $11M/d
Insufficient evidence for a screen-pass. GMR Solutions Inc.: fails the quant gate on momentum (Q61/V72/M33; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
COMPANY DESCRIPTION
GMR Solutions Inc. is a specialized healthcare services provider focused on operating and managing outpatient medical care facilities and diagnostic clinics. The company utilizes advanced medical technologies and streamlined patient workflows to deliver high-quality, cost-effective diagnostic and treatment services. Its competitive position is supported by strategic partnerships with regional healthcare networks and a focus on high-demand suburban markets.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.4B | 6.0B | 5.7B | 3.1% | 5.9B | 6.0B | 6.4B | 5.4% |
| EPS | -0.91 | -0.32 | 0.16 | — | -2.03 | 1.62 | 1.81 | 235.8% |
| Shares | — | 54.0M | 54.0M | 0.0% | 54.0M | — | — | — |
| Debt | — | 4.9B | 5.4B | 10.5% | 4.8B | — | — | — |
| Equity | — | 188.0M | 204.2M | 8.6% | — | — | — | — |
| Op CF | 257.8M | 246.2M | 641.1M | 57.7% | 639.8M | — | — | — |
| Inv CF | -143.0M | 48.0M | -250.0M | — | — | — | — | — |
| Fin CF | -142.2M | -59.2M | -135.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GMRS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| GMRS | GMR Solutions Inc.(you) | $681M | 72 | Buy |
| STLN | The Oncology Institute, Inc. | $629M | 63 | Hold |
| CYH | Community Health Systems, Inc. | $413M | 73 | Buy |
| USPH | U.S. Physical Therapy, Inc. | $1.2B | 62 | Hold |
| PNTG | The Pennant Group, Inc. | $1.3B | 64 | Hold |
| INNV | InnovAge Holding Corp. | $1.5B | 63 | Hold |
| ASTH | Astrana Health, Inc. | $1.9B | 83 | Strong Buy |
| ARDT | Ardent Health, Inc. | $1.5B | 88 | Strong Buy |
| SGRY | Surgery Partners, Inc. | $1.8B | 58 | Hold |
| SRTA | Strata Critical Medical, Inc. | $528M | 41 | Hold |
Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.3%